FULC - Fulcrum Therapeutics GAAP EPS of -$0.43 in-line
2024-05-13 07:22:58 ET
More on Fulcrum Therapeutics
- Fulcrum Therapeutics, Inc. (FULC) Q4 2023 Earnings Call Transcript
- Fulcrum hits 52-week high as CEO buys shares
- Seeking Alpha’s Quant Rating on Fulcrum Therapeutics
- Historical earnings data for Fulcrum Therapeutics
- Financial information for Fulcrum Therapeutics